A Trial of Camrelizumab Combined With Ablation and Chemotherapy in Patients With Pancreatic Cancer Liver Metastasis（SHR-1210-HLJ-009）
Clinical trial NCT04420130 · WITHDRAWN
Trial details
- NCT number
- NCT04420130
- Sponsor
- Yanqiao Zhang
- Status
- WITHDRAWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-01
- Primary completion
- 2022-08-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.